Transposon Therapeutics
Transposon Therapeutics, Inc.
San Diego, United States · Founded 2020 · $9.7M raised
- Headquarters
- San Diego, California
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- transposonrx.com
- Total Funding
- $9.7M
- Last Round
- $5.0M GrantJul 2025
- Rounds
- 2
About
Biotech company developing LINE-1 reverse transcriptase inhibitors including TPN-101 for rare neurological diseases such as PSP and ALS.
Summary
Transposon Therapeutics is a Biotech company based in San Diego, United States, founded in 2020. It has raised $9.7M in total across 2 rounds, most recently a $5.0M Grant round in Jul 2025. Investors include Alzheimer's Drug Discovery Foundation and Canaan Partners.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company